Annals of the Rheumatic Diseases · 2012 · 50 citations · 10 references
MedicineImmunologyNephrologyAutoimmunityInflammationRheumatologyAutoantibodiesAutoimmune DiseasesCytokine BiologyRenal InflammationRheumatoid ArthritisSystemic Lupus ErythematosusCytokine-mediated Renal InflammationDisease Activity MeasurementImmune Complex GlomerulonephritisImmune-mediated NephritisKidney Biopsy FindingsProinflammatory MediatorsSystemic Inflammation MarkersSystemic Lupus Erythematosus Associations
BACKGROUND: The soluble form of the interleukin 7 receptor (sIL-7R) is produced by fibroblasts after stimulation with proinflammatory cytokines. Increased sIL-7R serum and synovial fluid levels were recently demonstrated in patients with rheumatoid arthritis. OBJECTIVES: To investigate whether sIL-7R production is dysregulated in systemic lupus erythematosus (SLE), and whether this correlates with disease activity. METHODS: Serum and urine sIL-7R concentrations were measured by ELISA, and sIL-7R quantitative PCR (qPCR) studies were performed in peripheral blood mononuclear cells (PBMCs). IL-7R, tumour necrosis factor α (TNFα), IL-1β and IL-17 immunostainings were performed on kidney sections. RESULTS: sIL-7R concentrations were significantly higher in SLE sera than in controls, and correlated with SLE Disease Activity Index (SLEDAI) scores. Accordingly, serum sIL-7R levels were strongly raised in patients with nephritis. Moreover in patients with lupus nephritis, serum sIL-7R decreased upon treatment. sIL-7R gene expression in PBMCs was similar in patients with lupus nephritis and controls. By contrast, abundant perivascular IL-7R expression was seen in SLE kidney biopsy specimens, which was associated with expression of TNFα in the surrounding tissue. CONCLUSIONS: Our data indicate that sIL-7R is a marker of SLE disease activity, especially nephritis. In contrast to conventional disease activity markers, sIL-7R is not produced by immune cells, but might instead reflect activation of tissue cells in the target organ.
10
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Frédéric Houssiau, David D’Cruz, Shirish Sangle et al. · Annals of the Rheumatic Diseases · 2010 · 496 citations · Full text
Prevention of relapses in systemic lupus erythematosus
Hendrika Bootsma, Peter E. Spronk, G. de Boer et al. · The Lancet · 1995 · 292 citations